Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.
CAPACITY: A physical activity self-management program for patients undergoing surgery for lung cancer, a phase I feasibility study
Granger, CL; Irving, L; Antippa, P; Edbrooke, L; Parry, SM; Krishnasamy, M; Denehy, L
(2018), Lung Cancer, 102-109
A hospital and home-based exercise program to address functional decline in people following allogeneic stem cell transplantation
Abo, S; Ritchie, D; Denehy, L; Panek-Hudson, Y; Irving, L; Granger, CL
(2018), Support. Care Cancer, 1727-1736
Measurement of physical activity in clinical practice and research: advances in cancer and chronic respiratory disease
Maddocks, M; Granger, CL
(2018), Curr. Opin Support Palliat. Car., 219-226
Advanced musculoskeletal physiotherapists in post arthroplasty review clinics: a state wide implementation program evaluation
Harding, P; Burge, A; Walter, K; Shaw, B; Page, C; Phan, U; Terrill, D; Liew, S
(2018), Physiotherapy, 98-106
Uptake of telehealth implementation for COPD patients in a high-poverty, inner-city environment: A survey
Granger, CL; Wijayarathna, R; Suh, ES; Arbane, G; Denehy, L; Murphy, P; Hart, N
(2018), Chronic Respir. Dis., 81-84
Evidence, education and multi-disciplinary integration are needed to embed exercise into lung cancer clinical care: A qualitative study involving physiotherapists
Granger, CL; Parry, SM; Denehy, L; Remedios, L
(2018), Physiother. Theory Pract., 852-860
The nexus of functional exercise capacity with health-related quality of life in lung cancer: how closely are they related?
Granger, CL; Edbrooke, L; Denehy, L
(2018), ANN. TRANSL. MED.
Critically appraised paper: Short-term preoperative exercise training improves exercise capacity and reduces postoperative pulmonary complications in people undergoing lung cancer surgery
Granger, C
(2018), J. Physiother., 266-266
Questions to ask a patient with nocturia
Bower, WF; Everaert, K; Ong, TJ; Ervin, CF; Norgaard, JP; Whishaw, M
(2018), Aust. J. Gen. Pract., 465-469
The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas
Rogers, TW; Toor, G; Drummond, K; Love, C; Field, K; Asher, R; Tsui, A; Buckland, M; Gonzales, M
(2018), J. Neuro-Oncol., 181-189
Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience
Loveland, P; Christie, M; Hammerschlag, G; Irving, L; Steinfort, D
(2018), Intern. Med. J., 1318-1324
DOI: 10.1111/imj.13991
Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond
Wong, HL; Christie, M; Gately, L; Tie, J; Lee, B; Semira, C; Lok, SW; Wong, R; Gibbs, P
(2018), Future Oncol., 2725-2740
Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study
Shapiro, JD; Thavaneswaran, S; Underhill, CR; Robledo, KP; Karapetis, CS; Day, FL; Nott, LM; Jefford, M; Chantrill, LA; Pavlakis, N; Tebbutt, NC; Price, TJ; Khasraw, M; Van Hazel, GA; Waring, PM; Tejpar, S; Simes, J; Gebski, VJ; Desai, J; Segelov, E
(2018), Clin. Colorectal Canc., 313-319
MRI Features Can Predict 1p/19q Status in Intracranial Gliomas
Lasocki, A; Gaillard, F; Gorelik, A; Gonzales, M
(2018), Am. J. Neuroradiol., 687-692
DOI: 10.3174/ajnr.A5572
Routine use of HbA1c amongst inpatients hospitalised with decompensated heart failure and the association of dysglycaemia with outcomes
Khoo, K; Lew, J; Neef, P; Kearney, L; Churilov, L; Robbins, R; Tan, A; Hachem, M; Owen-Jones, L; Lam, Q; Hart, GK; Wilson, A; Sumithran, P; Johnson, D; Srivastava, PM; Farouque, O; Burrell, LM; Zajac, JD; Ekinci, EI
(2018), Sci Rep
DNA mismatch repair protein deficient non-neoplastic colonic crypts: a novel indicator of Lynch syndrome
Pai, RK; Dudley, B; Karloski, E; Brand, RE; O'Callaghan, N; Rosty, C; Buchanan, DD; Jenkins, MA; Thibodeau, SN; French, AJ; Lindor, NM; Pai, RK
(2018), Mod. Pathol., 1608-1618
Update on Hereditary Colorectal Cancer: Improving the Clinical Utility of Multigene Panel Testing
Lorans, M; Dow, E; Macrae, FA; Winship, IM; Buchanan, DD
(2018), Clin. Colorectal Canc., E293-E305
Risk and prognostic factors for endometrial carcinoma after diagnosis of breast or Lynch-associated cancers-A population-based analysis
Johnatty, SE; Stewart, CJR; Smith, D; Buchanan, D; Leung, Y; Oehler, MK; Brand, A; Webb, PM; Spurdle, AB
(2018), Cancer Med., 6411-6422
DOI: 10.1002/cam4.1890
polyClustR: defining communities of reconciled cancer subtypes with biological and prognostic significance
Eason, K; Nyamundanda, G; Sadanandam, A
(2018), BMC Bioinformatics
Association of DNA Methylation-Based Biological Age With Health Risk Factors and Overall and Cause-Specific Mortality
Dugue, PA; Bassett, JK; Joo, JE; Baglietto, L; Jung, CH; Wong, EM; Fiorito, G; Schmidt, D; Makalic, E; Li, S; Moreno-Betancur, M; Buchanan, DD; Vineis, P; English, DR; Hopper, JL; Severi, G; Southey, MC; Giles, GG; Milne, RL
(2018), Am. J. Epidemiol., 529-538
DOI: 10.1093/aje/kwx291
Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population
Cenin, DR; Naber, SK; Lansdorp-Vogelaar, I; Jenkins, MA; Buchanan, DD; Preen, DB; Ee, HC; O'Leary, P
(2018), J. Gastroenterol. Hepatol., 1737-1744
DOI: 10.1111/jgh.14154
Infantile-Onset Myelin Protein Zero-Related Demyelinating Neuropathy Presenting as an Upper Extremity Monoplegia
Yiu, EM; Wanigasinghe, J; Mackay, MT; Gonzales, M; Nicholson, G; Ryan, MM
(2018), Semin. Pediatr. Neurol., 52-55
The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial
Mooi, JK; Wirapati, P; Asher, R; Lee, CK; Savas, P; Price, TJ; Townsend, A; Hardingham, J; Buchanan, D; Williams, D; Tejpar, S; Mariadason, JM; Tebbutt, NC
(2018), Ann. Oncol., 2240-2246
Health service impact of testing for respiratory pathogens using cartridge-based multiplex array versus molecular batch testing
Madigan, VM; Sinickas, VG; Giltrap, D; Kyriakou, P; Ryan, K; Chan, HT; Clifford, V
(2018), Pathology, 758-763
Emerging biomarkers for immunomodulatory cancer treatment of upper gastrointestinal, pancreatic and hepatic cancers
Lee, B; Hutchinson, R; Wong, HL; Tie, J; Putoczki, T; Tran, B; Gibbs, P; Christie, M
(2018), Semin. Cancer Biol., 241-252
Lifetime alcohol intake and risk of non-Hodgkin lymphoma: Findings from the Melbourne Collaborative Cohort Study
Jayasekara, H; Juneja, S; Hodge, AM; Room, R; Milne, RL; Hopper, JL; English, DR; Giles, GG; MacInnis, RJ
(2018), Int. J. Cancer, 919-926
DOI: 10.1002/ijc.31123
Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype
Jayasekara, H; English, DR; Haydon, A; Hodge, AM; Lynch, BM; Rosty, C; Williamson, EJ; Clendenning, M; Southey, MC; Jenkins, MA; Room, R; Hopper, JL; Milne, RL; Buchanan, DD; Giles, GG; MacInnis, RJ
(2018), Int. J. Cancer, 238-250
DOI: 10.1002/ijc.31049
Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species
Foliaki, ST; Lewis, V; Finkelstein, DI; Lawson, V; Coleman, HA; Senesi, M; Islam, AMT; Chen, F; Sarros, S; Roberts, B; Adlard, PA; Collins, SJ
(2018), PLoS Pathog.
Semi-Solid and Solid Dosage Forms for the Delivery of Phage Therapy to Epithelia
Brown, TL; Petrovski, S; Chan, HT; Angove, MJ; Tucci, J
(2018), Pharmaceuticals
DOI: 10.3390/ph11010026
Responding to urgency of need: Initial qualitative stage in the development of a triage tool for use in palliative care services
Russell, B; Sundararajan, V; Hennesy-Anderson, N; Collins, A; Burchell, J; Vogrin, S; Le, B; Brand, C; Hudson, P; Philip, J
(2018), Palliat. Med., 1246-1254